BD To Commercialize RFID-Smart Syringes For Unit-Level Supply Chain Traceability

A collaboration with pharma contract manufacturer ten23 health fills BD’s new smart, RFID-tagged prefillable syringes to improve traceability from aseptic filling and beyond.

At a Glance

  • Pilot tests demonstrate how prefilled syringes can be tracked through manufacturing and distribution.
  • Standards-compliant software allows data visibility to multiple supply chain partners.
  • Once the smart syringes are introduced, customers will determine how packaging will inform the marketplace.

Mix-ups of prefilled syringes (PFSs) can occur at any stage of the manufacturing process — a mistake that could result in lost productivity, costly recalls, and risk to the patient. 

Current traceability solutions for PFSs rely on lot numbers that denote which syringes are used for a specific drug lot, which means there is no tracking of single units for the fill-finish process. In contrast, BD’s iDFill promises to track each individual PFS, not only during distribution but during every step of the manufacturing process. By focusing on individual units instead of batches, the solution is purported to offer greater process visibility and efficiency and allow for quicker identification and tracking of individual units.

The product is still in development and is being tested by BD in partnership with contract development and manufacturing partner ten23 health.

How does it work?

The RFID tag is incorporated into the rigid needle shield (RNS) of the syringe outside of the fluid path, ensuring that it doesn’t come into contact with the drug. The tag, which is compatible with ethylene oxide (EtO) and E-beam sterilization, is sterilized with the syringe/needle presentation. The addition of the tag does not alter the RNS dimensions and maintains compatibility with secondary devices, such as auto-injectors and safety devices.

Each tag is encoded with a unique serial number called the container unique identifier (CUID). This CUID can be scanned at various stages of the manufacturing process, from filling to secondary packaging or any further assembly. By linking the drug code, filling batch, timestamps, and other relevant data with the CUID, the solution provides full container traceability and enables multiple applications, including automated reconciliation, mix-up prevention, and investigation management.

How will iDFill work in practical terms? At the end of BD’s manufacturing line, tagged syringes are placed into a tub and their CUIDs are read and aggregated to the tub/nest Identifier (ID). This aggregation of parent and child ensures tag readability and establishes data integrity and syringe pedigree. At the customer site’s filling line, one reading of the tub/nest ID is enough to associate it with its current drug filling batch; the syringe ID can be cross-checked at each subsequent process step to prevent mix-ups, and additional manufacturing events are expected to be recorded to build a full syringe pedigree. Prior to shipping, the pedigree can be confirmed by its data, showing the product’s movement at every step, continuing to offer data accessibility after the PFS sale and shipment.

According to ten23 health, customers will need to determine how best to call attention to the RFID tag based on the individual product and its intended use. One method is to use graphics on labels or packaging that alert supply chain and healthcare professionals to the presence of the RFID tag on the PFS and guide its use. 

Reading and Tracking the Data

Crypto Pharma was selected by ten23 to provide IDFill’s tracking software, which is tailored to customers’ needs and specific pharmaceutical industry requirements. To allow data exchange among various parties, the data architecture adheres to the International Society for Pharmaceutical Engineering’s (ISPE) Good Practice Guide: Unique ID of Glass Primary Containers. Additionally, RFID tag communication follows the globally established GS1 specification and ISO/IEC 18000-63.

RFID-tagged PFS can be read using broadly available RFID readers and various software; however, hardware adaptations might be needed to fulfill regulatory requirements in cleanroom environments.

The cost for iDFill varies, depending on the volume of individual units purchased as well as the investment in ten23 health and associated services for fill-finish operations.

Written by: Kassandra Kania, Freelance Writer

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.